<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">
      <span class="gem-c-organisation-logo__name">Medicines &amp; Healthcare products<br>Regulatory Agency</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Open consultation
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    Consultation questions
  </h1>
</div>
  <p class="publication-header__last-changed">Published 31 August 2022</p>

  </header>






<div class="sidebar-with-body">
  <div class="govuk-grid-row">

    <div class="print-wrapper">
      <div class="print-meta-data">
        <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-93b6a51b518ff99714a1aa2a7d2162735c155ec3cb073c75fb88b2a332fa83d3.png">
</p>
<p>
  Â© Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/consultations/consultation-on-proposals-for-changes-to-the-medicines-and-healthcare-products-regulatory-agencys-statutory-fees/consultation-questions
</p>


      </div>
    </div>

    <div class="main-content-container offset-empty-contents-list">
      <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
        <div class="govspeak">
<h3>Question 1</h3>

<p>Do you support proposal 1, to apply a 10% indexation uplift across Agency statutory fees to match the increased pay costs national average since the last MHRA fees review?</p>

<h3>Question 2</h3>

<p>Do you support proposal 2, to place a cost-based uplift for 61 significantly under recovering fees to achieve full cost recovery?</p>

<h3>Question 3</h3>

<p>Do you support proposal 3 to introduce 22 new fees for services offered by the MHRA?</p>

<h3>Question 4</h3>

<p>Would you consider these proposals to impact certain types of business disproportionately? e.g. small businesses?</p>

<h3>Question 5</h3>

<p>Do you think any of the proposals in this consultation could have an impact on the development and access to medicines or devices for (1) rare conditions or (2) minority groups with smaller patient populations?</p>

<h3>Question 6</h3>

<p>Do you think any of the proposals in this consultation pose a risk to existing products being withdrawn from the UK market?</p>

<h3>Question 7</h3>

<p>Do you think any of the proposals in this consultation could have an impact on research, clinical trials or clinical investigations in the UK?</p>

<h3>Question 8</h3>

<p>With reference to the protected characteristics covered by the Public Sector Equality Duty set out in section 149 of the Equality Act 2010 or by section 75 of the Northern Ireland Act 1998, we do not consider that our proposals risk impacting different people differently with reference to their protected characteristics. Do you agree?</p>

<h3>Question 9</h3>

<p>In Northern Ireland new policies must be screened under Section 75 of the&nbsp;<a class="govuk-link" href="https://www.legislation.gov.uk/ukpga/1998/47/section/75" rel="external">Northern Ireland Act 1998</a>&nbsp;which requires public authorities to have due regard to rural needs.</p>

<p>We do not consider that our proposals risk impacting different people differently with reference to their protected characteristics or where they live in Northern Ireland. Do you agree? Yes/No.</p>
</div>


</div>
</div>
    </div>
  </div>

  <div class="govuk-grid-row">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Back to top
</a>

  </div>
</div>

    </main>